ScripVertex Pharmaceuticals Incorporated has experience shifting focus, having transitioned rapidly from a hepatitis C specialist to its current concentration on cystic fibrosis, and its 8 December collab
ScripThe ongoing financial market turmoil for biopharma has put an end to Amicus Therapeutics, Inc. ’s plan to spin out its gene therapy business in a separate publicly traded company called Caritas Ther